Elizabeth R. Gebarski, Associate

Publications and Presentations

10/16/18 – Presentation

Roger N. Morris

"The Year in Review - A Legal Case Update"Western Medicaid Pharmacy Administrators Association Annual ConferenceBy Roger N. Morris, Elizabeth Gebarski

05/15/18 – Newsletter OIG Blesses Arrangement Involving "Far Removed" Excluded Person OIG Monitor Elizabeth Gebarski

02/02/17 – Blog "The Omnibus Guidance is Dead!" To Be or Not to 340B By Alyce C. Katayama and Elizabeth R. Gebarski

08/18/16 – Presentation “The 340B Drug Pricing Program: Staying Afloat in the Wake of the Omnibus Guidance” Health, Labor, and Employment Law Institute By Alyce C. Katayama and Elizabeth R. Gebarski

06/28/16 "Cyber Health Crisis: How to Manage the Risk" Health Law Handbook 2016 Edition By Elizabeth R. Gebarski, co-contributing author

06/22/16 – Blog "Don’t Expose Your ePHI by Using Vulnerable Third-Party Applications" Safe and Sound By Elizabeth R. Gebarski

05/01/16 – Article "Health Law" Chapter for Annual Survey of Wisconsin Law, 2016 Edition By Alyce C. Katayama, Sarah E. Coyne, Elizabeth R. Gebarski, Samuel A. Magnuson

03/16/16 – Blog "Key Takeaway from 340B Conferences – Audits" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

03/09/16 – Blog "Comparing 340B University and the 340B Coalition Conference" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

02/29/16 – Blog "Top Takeaway from 340B University and 340B Coalition Conference" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

02/24/16 – Blog "Federal Agencies Release Guidance on Cyber Sharing" Safe and Sound By Heather L. Buchta and Elizabeth R. Gebarski

02/03/16 – Article "Unexpected Uncertainty For The 340B Drug Pricing Program" Law 360 By Alyce C. Katayama and Elizabeth R. Gebarski

01/11/16 – Blog "Site Neutral Payments Put 340B Child Sites in Jeopardy" To Be or Not to 340B By Alyce C. Katayama and Elizabeth R. Gebarski

01/04/16 – Blog "Approved – Cybersecurity Act of 2015" Safe and Sound By Elizabeth R. Gebarski

12/31/15 – Blog "End of Year Thoughts on FTC Data & Security Requirements" Safe and Sound By John L. Barlament, Elizabeth R. Gebarski

12/14/15 – Article "The 340B Drug Pricing Program Omnibus Guidance – Part Two" Pharmaceutical Compliance Monitor By Alyce C. Katayama and Elizabeth R. Gebarski

11/13/15 – Article "The 340B Drug Pricing Program Omnibus Guidance – in Two Parts" Pharmaceutical Compliance Monitor By Alyce C. Katayama and Elizabeth R. Gebarski

10/30/15 – Blog "U.S. Senate Encourages Sharing – of Cyber Threat Indicators, That Is" Safe and Sound By John L. Barlament and Elizabeth R. Gebarski

10/22/15 – Article "Don't Forget Child Sites Under The 340B Omnibus Guidance" Law360 By Alyce C. Katayama and Elizabeth R. Gebarski

10/19/15 – Blog "PhRMA 2-0 in The Orphan Drug Wars" To Be or Not to 340B By Alyce C. Katayama and Elizabeth R. Gebarski

10/12/15 – Blog "Breaking Down the Proposed Omnibus Guidance – Child Sites" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

10/01/15 – Newsletter T​he 340B Program Mega Guidance: Muddying the Water for All Stakeholders Health Law Alert Alyce C. Katayama, Edward D. Rickert, Brenda M. Maloney Shafer, Elizabeth R. Gebarski

09/17/15 – Blog "Breaking Down the Proposed Omnibus Guidance – Covered Entity Eligibility, Registration & Termination" To Be or Not to 340B By Alyce C. Katayama and Elizabeth R. Gebarski

08/28/15 – Blog "The Proposed 340B Drug Pricing Program Omnibus Guidelines Have Landed To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

08/19/15 – Blog "Target Settles with Visa Card Issuers for Up to $67 Million" Safe and Sound By Elizabeth R. Gebarski and John L. Barlament

06/22/15 – Article "Health Law" Chapter for Annual Survey of Wisconsin Law, 2015 Edition By Sarah E. Coyne, Elizabeth R. Gebarski, Alyce C. Katayama

06/18/15 – Blog "Finally! HRSA Proposes Manufacturer Civil Monetary Penalties" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

05/28/15 – Blog "Near Miss on Congressional Overhaul of 340B Program" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

05/14/15 – Blog "How Much Will You Pay for an Inaccurate 340B Ceiling Price?" To Be or Not To 340B By Alyce C. Katayama and Elizabeth R. Gebarski

05/14/15 – Newsletter Are You Interested in the FDA's Guidance on Outsourcing Facilities? Your Time to Comment Is Ending Soon! Health Law Alert Susan Trujillo, Ed Rickert, Nick Meza, Ashley Strait, Elizabeth Gebarski

• Page 1 of 2
• Next